Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: Determination of drug concentration thresholds using a dilution titration technique

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 5, 2003, Pages 576-582

  Berg, C M ^a   Heier, Tom ^a   Wilhelmsen, V ^a   Florvaag, E ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Allergy; Cisatracurium; Rocuronium, muscle relaxant; Skin test, intradermal test, skin prick test, muscle relaxant

Indexed keywords

AMINE; CISATRACURIUM; MUSCLE RELAXANT AGENT; ROCURONIUM;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRACUTANEOUS TEST; MALE; MAST CELL DEGRANULATION; NORMAL HUMAN; PRICK TEST; PRIORITY JOURNAL; SKIN TEST; TECHNIQUE; TITRIMETRY;

ADOLESCENT; ADULT; ANDROSTANOLS; ATRACURIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; FEMALE; HISTAMINE RELEASE; HUMANS; INDICATOR DILUTION TECHNIQUES; MALE; MAST CELLS; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; REGRESSION ANALYSIS; RISK ASSESSMENT; SKIN; SKIN TESTS;

EID: 0038637796     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00093.x     Document Type: Article

References (27)

1. Johansson SG, Hourihane JO, Bousquet J et al. EAACI (the European Academy of Allergology and Cinical Immunology). A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-24.
2. Gueant JL, Aimone-Gastin I, Namour F, Laroche D, Bellou A, Laxenaire MC. Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy 1998; 28 (Suppl. 70):.
3. Laxenaire MC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993; 12: 91-6.
4. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104.
5. Didier A, Cador D, Bongrand P et al. Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol 1987; 79: 578-84.
6. Tamayo E, Perez M, Gomez JI, Alvarez FJ. Allergy of anaesthetizing agents in Spain. Br J Anaesth 1999; 83: 336-7.
7. Fisher MM, Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 1983; 62: 559-64.
8. Leynadier F, Sansarricq M, Didier JM, Dry J. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987; 59: 683-9.
9. Levy JH, Gottge M, Szlam F, Zaffer R, McCall C. Weal and flare responses to intradermal rocuronium and cisatracurium in humans. Br J Anaesth 2000; 85: 844-9.
10. Levy JH, Adelson D, Walker B. Wheal and flare responses to muscle relaxants in humans. Agents Actions 1991; 34: 302-8.
11. Guilloux L, Ricard-Blum S, Ville G, Motin J. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992; 90: 153-9.
12. Gueant JL, Mata E, Monin B et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991; 46: 452-8.
13. Osterballe O, Weeke B. A new lancet for skin prick testing. Allergy 1979; 34: 209-12.
14. Skin tests used in type I. allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44 (Suppl.): 59.
15. Bosquet M, Francois-Bernard M. In vivo methods for study of allergy. In: Middleton E, Reed C E, Ellis E F, Franklin Adkinson N, Yunginger J W, Busse W W, eds. Allergy - Principles and Practice, Vol. I. St. Louis: Mosby, 1993; 573-94.
16. Fisher MM, Bowey CJ. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79: 59-63.
17. Laxenaire MC, Mertes PM, GERAP. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58.
18. Dib S, Grimfeld A, Sahraoui F, Timsit S, Just J. Prevalence of latex sensitization in infants and young children with asthma. Rev Fr Allergol Immunol Clin 2001; 41: 382-8.
19. Dvorak AM, Massey W, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood 1991; 77: 569-78.
20. Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey. -December 1996) Ann Fr Anesth Reanim, July 1994: 1999 (18); 796-809.
21. Aalen OO. Binomial Distribution. Oslo: Ad Notam Gyldendal AS, 1994.
22. Watkins J. Adverse reaction to neuromuscular blockers: frequency, investigation, epidemiology. Acta Anaesthesiol Suppl 1994; 102: 6-10.
23. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678-82.
24. Laxenaire MC, Gastin I, Moneret-Vautrin DA, Widmer S, Gueant JL. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol Suppl 1995; 11: 55-64.
25. Yamaguchi K, Haurax C, Szlam F, Levy JH. Vascular effects of ORG9487 in human mammary arteries, a new short acting muscle relaxant. Anesthesiology 1998; 86: SCA 109.
26. 2-sufentanil anesthesia. Anesth Analg 1994; 78: 318-21.
27. Lien CA, Belmont MR, Abalos A et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1131-8.